Pharmacologically Relevant Bifunctional Compounds Containing Chloroquinoline and Dihydropyrimidone Moieties: Syntheses and Crystal Structures of a Target Molecule and Selected Intermediates
作者:Nicholas D. Watermeyer、Kelly Chibale、Mino R. Caira
DOI:10.1007/s10870-009-9568-2
日期:2009.10
We report the regioselective synthesis and X-ray structure of the pharmacologically relevant 3-[2-(7-chloro-quinolin-4-ylamino)-ethylcarbamoyl]-4-(4-methoxy-phenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid methyl ester (3) (triclinic, space group $$ P\bar1} $$ , a = 11.1775 (3), b = 13.6470 (4), c = 16.3680 (6) Å, α = 82.645 (1), β = 86.423 (1), γ = 88.415 (2)°, V = 2470.9 (1) Å3, Z = 4). Further support for the regioselectivity is provided by the X-ray structures of two intermediates, namely 4-(4-methoxy-phenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid methyl ester, 8 (monoclinic, space group P21/c, a = 11.7710 (2), b = 5.5290 (1), c = 22.9500 (5) Å, β = 104.342 (1)°, V = 1447.08 (5) Å3, Z = 4), and 4-(4-methoxy-phenyl)-1,3,6-trimethyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid methyl ester, 9 (monoclinic, space group P21/c, a = 16.6529 (7), b = 10.9426 (4), c = 8.2819 (3) Å, β = 91.395 (2)°, V = 1508.7 (1) Å3, Z = 4), which are also reported. The three compounds display significant differences in the conformations of their DHPM rings as well as a variety of hydrogen bonding arrangements in their crystals. The synthetic strategy for deriving pharmacologically-relevant bifunctional compounds based on linked dihydropyrimidone and chloroquinoline moieties is reported, together with supporting X-ray structures of two synthetic intermediates and a representative target compound.
我们报道了药理学相关的3-[2-(7-氯-喹啉-4-基氨基)-乙基氨基甲酰基]-4-(4-甲氧基-苯基)-1,6-二甲基-的区域选择性合成和X射线结构。 2-氧代-1,2,3,4-四氢-嘧啶-5-甲酸甲酯 (3)(三斜晶系,空间群 $$ P\bar1} $$ , a = 11.1775 (3), b = 13.6470 (4)、c = 16.3680 (6) Å、α = 82.645 (1)、β = 86.423 (1)、γ = 88.415 (2)°、V = 2470.9 (1) Å3、Z = 4)。两种中间体的X射线结构进一步支持了区域选择性,即4-(4-甲氧基-苯基)-1,6-二甲基-2-氧代-1,2,3,4-四氢-嘧啶- 5-羧酸甲酯,8(单斜晶系,空间群 P21/c,a = 11.7710 (2),b = 5.5290 (1),c = 22.9500 (5) Å,β = 104.342 (1)°,V = 1447.08 (5) Å3, Z = 4), 和 4-(4-甲氧基-苯基)-1,3,6-三甲基-2-氧代-1,2,3,4-四氢-嘧啶-5-甲酸甲基酯,9(单斜晶系,空间群 P21/c,a = 16.6529 (7),b = 10.9426 (4),c = 8.2819 (3) Å,β = 91.395 (2)°,V = 1508.7 (1) Å3, Z = 4),这也被报告。这三种化合物在 DHPM 环的构象以及晶体中的各种氢键排列方面表现出显着差异。报道了基于连接的二氢嘧啶酮和氯喹啉部分衍生药理学相关双功能化合物的合成策略,以及两种合成中间体和代表性目标化合物的支持X射线结构。